Platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio as predictors of refractory anaphylaxis

Refractory anaphylaxis poses an ongoing, lethal hypersensitivity response that unpredictably involves multiple organs despite appropriate intramuscular (IM) adrenaline injections. Studies on the association of the platelet-to-lymphocyte ratio (PLR) and neutrophil-to-lymphocyte ratio (NLR) concerning...

Full description

Saved in:
Bibliographic Details
Published inThe World Allergy Organization journal Vol. 17; no. 8; p. 100944
Main Authors Nghi, Le Vinh, Phuc, Nguyen Hoang, Hai, Pham Dang
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 01.08.2024
Elsevier BV
Elsevier
Subjects
Online AccessGet full text
ISSN1939-4551
1939-4551
DOI10.1016/j.waojou.2024.100944

Cover

Abstract Refractory anaphylaxis poses an ongoing, lethal hypersensitivity response that unpredictably involves multiple organs despite appropriate intramuscular (IM) adrenaline injections. Studies on the association of the platelet-to-lymphocyte ratio (PLR) and neutrophil-to-lymphocyte ratio (NLR) concerning anaphylactic severity have yet to be carried out. The study aimed to evaluate the association between blood PLR and NLR levels and refractory anaphylaxis. We carried out a retrospective cross-sectional study in which medical records of patients with anaphylaxis who sought urgent care at the Emergency Department (ED) of Tertiary Hospital in Hanoi, Vietnam, were evaluated. Based on the United Kingdom Resuscitation Council guidelines in 2021, patients were classified as refractory anaphylaxis if they needed more than two appropriate doses of intramuscular adrenaline for anaphylactic symptoms resolution. Clinical data and laboratory results were obtained in the medical records. Logistic regression analysis determined the association between contributing factors and refractory anaphylaxis. One-hundred eighteen adults (age 51.80 ± 18.25 years) were analyzed, including 38 refractory anaphylaxis patients (32.2%). Refractory anaphylaxis patients exhibited notably elevated platelet-to-lymphocyte ratio (PLR) (P = 0.006) and increased neutrophil-to-lymphocyte ratio (NLR) (P < 0.001) in comparison to non-refractory anaphylaxis patients. Receiver operating characteristic curve (ROC) analysis demonstrated an optimal PLR cutoff value of 129.5 (area under the ROC curve [AUC] 0.658, sensitivity 73.68%, specificity 61.25%, P = 0.004) and an optimal NLR cutoff value of 4 (AUC 0.736, sensitivity 65.79%, specificity 73.75%, P < 0.001) for refractory anaphylaxis. Multivariate logistic regression analysis revealed a PLR≥129.5 (OR = 4.83, 95% CI: 1.87–12.48) and an NLR≥4 (OR = 4.60, 95% CI: 1.86–11.41) were independently associated with refractory anaphylaxis. Elevated PLR and NLR serve as independent indicators significantly associated with refractory anaphylaxis.
AbstractList Refractory anaphylaxis poses an ongoing, lethal hypersensitivity response that unpredictably involves multiple organs despite appropriate intramuscular (IM) adrenaline injections. Studies on the association of the platelet-to-lymphocyte ratio (PLR) and neutrophil-to-lymphocyte ratio (NLR) concerning anaphylactic severity have yet to be carried out. The study aimed to evaluate the association between blood PLR and NLR levels and refractory anaphylaxis. We carried out a retrospective cross-sectional study in which medical records of patients with anaphylaxis who sought urgent care at the Emergency Department (ED) of Tertiary Hospital in Hanoi, Vietnam, were evaluated. Based on the United Kingdom Resuscitation Council guidelines in 2021, patients were classified as refractory anaphylaxis if they needed more than two appropriate doses of intramuscular adrenaline for anaphylactic symptoms resolution. Clinical data and laboratory results were obtained in the medical records. Logistic regression analysis determined the association between contributing factors and refractory anaphylaxis. One-hundred eighteen adults (age 51.80 ± 18.25 years) were analyzed, including 38 refractory anaphylaxis patients (32.2%). Refractory anaphylaxis patients exhibited notably elevated platelet-to-lymphocyte ratio (PLR) (  = 0.006) and increased neutrophil-to-lymphocyte ratio (NLR) (  < 0.001) in comparison to non-refractory anaphylaxis patients. Receiver operating characteristic curve (ROC) analysis demonstrated an optimal PLR cutoff value of 129.5 (area under the ROC curve [AUC] 0.658, sensitivity 73.68%, specificity 61.25%,  = 0.004) and an optimal NLR cutoff value of 4 (AUC 0.736, sensitivity 65.79%, specificity 73.75%,  < 0.001) for refractory anaphylaxis. Multivariate logistic regression analysis revealed a PLR≥129.5 (OR = 4.83, 95% CI: 1.87-12.48) and an NLR≥4 (OR = 4.60, 95% CI: 1.86-11.41) were independently associated with refractory anaphylaxis. Elevated PLR and NLR serve as independent indicators significantly associated with refractory anaphylaxis.
Background: Refractory anaphylaxis poses an ongoing, lethal hypersensitivity response that unpredictably involves multiple organs despite appropriate intramuscular (IM) adrenaline injections. Studies on the association of the platelet-to-lymphocyte ratio (PLR) and neutrophil-to-lymphocyte ratio (NLR) concerning anaphylactic severity have yet to be carried out. The study aimed to evaluate the association between blood PLR and NLR levels and refractory anaphylaxis. Methods: We carried out a retrospective cross-sectional study in which medical records of patients with anaphylaxis who sought urgent care at the Emergency Department (ED) of Tertiary Hospital in Hanoi, Vietnam, were evaluated. Based on the United Kingdom Resuscitation Council guidelines in 2021, patients were classified as refractory anaphylaxis if they needed more than two appropriate doses of intramuscular adrenaline for anaphylactic symptoms resolution. Clinical data and laboratory results were obtained in the medical records. Logistic regression analysis determined the association between contributing factors and refractory anaphylaxis. Results: One-hundred eighteen adults (age 51.80 ± 18.25 years) were analyzed, including 38 refractory anaphylaxis patients (32.2%). Refractory anaphylaxis patients exhibited notably elevated platelet-to-lymphocyte ratio (PLR) (P = 0.006) and increased neutrophil-to-lymphocyte ratio (NLR) (P < 0.001) in comparison to non-refractory anaphylaxis patients. Receiver operating characteristic curve (ROC) analysis demonstrated an optimal PLR cutoff value of 129.5 (area under the ROC curve [AUC] 0.658, sensitivity 73.68%, specificity 61.25%, P = 0.004) and an optimal NLR cutoff value of 4 (AUC 0.736, sensitivity 65.79%, specificity 73.75%, P < 0.001) for refractory anaphylaxis. Multivariate logistic regression analysis revealed a PLR≥129.5 (OR = 4.83, 95% CI: 1.87–12.48) and an NLR≥4 (OR = 4.60, 95% CI: 1.86–11.41) were independently associated with refractory anaphylaxis. Conclusion: Elevated PLR and NLR serve as independent indicators significantly associated with refractory anaphylaxis.
Refractory anaphylaxis poses an ongoing, lethal hypersensitivity response that unpredictably involves multiple organs despite appropriate intramuscular (IM) adrenaline injections. Studies on the association of the platelet-to-lymphocyte ratio (PLR) and neutrophil-to-lymphocyte ratio (NLR) concerning anaphylactic severity have yet to be carried out. The study aimed to evaluate the association between blood PLR and NLR levels and refractory anaphylaxis. We carried out a retrospective cross-sectional study in which medical records of patients with anaphylaxis who sought urgent care at the Emergency Department (ED) of Tertiary Hospital in Hanoi, Vietnam, were evaluated. Based on the United Kingdom Resuscitation Council guidelines in 2021, patients were classified as refractory anaphylaxis if they needed more than two appropriate doses of intramuscular adrenaline for anaphylactic symptoms resolution. Clinical data and laboratory results were obtained in the medical records. Logistic regression analysis determined the association between contributing factors and refractory anaphylaxis. One-hundred eighteen adults (age 51.80 ± 18.25 years) were analyzed, including 38 refractory anaphylaxis patients (32.2%). Refractory anaphylaxis patients exhibited notably elevated platelet-to-lymphocyte ratio (PLR) (P = 0.006) and increased neutrophil-to-lymphocyte ratio (NLR) (P < 0.001) in comparison to non-refractory anaphylaxis patients. Receiver operating characteristic curve (ROC) analysis demonstrated an optimal PLR cutoff value of 129.5 (area under the ROC curve [AUC] 0.658, sensitivity 73.68%, specificity 61.25%, P = 0.004) and an optimal NLR cutoff value of 4 (AUC 0.736, sensitivity 65.79%, specificity 73.75%, P < 0.001) for refractory anaphylaxis. Multivariate logistic regression analysis revealed a PLR≥129.5 (OR = 4.83, 95% CI: 1.87–12.48) and an NLR≥4 (OR = 4.60, 95% CI: 1.86–11.41) were independently associated with refractory anaphylaxis. Elevated PLR and NLR serve as independent indicators significantly associated with refractory anaphylaxis.
Background Refractory anaphylaxis poses an ongoing, lethal hypersensitivity response that unpredictably involves multiple organs despite appropriate intramuscular (IM) adrenaline injections. Studies on the association of the platelet-to-lymphocyte ratio (PLR) and neutrophil-to-lymphocyte ratio (NLR) concerning anaphylactic severity have yet to be carried out. The study aimed to evaluate the association between blood PLR and NLR levels and refractory anaphylaxis. Methods We carried out a retrospective cross-sectional study in which medical records of patients with anaphylaxis who sought urgent care at the Emergency Department (ED) of Tertiary Hospital in Hanoi, Vietnam, were evaluated. Based on the United Kingdom Resuscitation Council guidelines in 2021, patients were classified as refractory anaphylaxis if they needed more than two appropriate doses of intramuscular adrenaline for anaphylactic symptoms resolution. Clinical data and laboratory results were obtained in the medical records. Logistic regression analysis determined the association between contributing factors and refractory anaphylaxis. Results One-hundred eighteen adults (age 51.80 ± 18.25 years) were analyzed, including 38 refractory anaphylaxis patients (32.2%). Refractory anaphylaxis patients exhibited notably elevated platelet-to-lymphocyte ratio (PLR) ( P = 0.006) and increased neutrophil-to-lymphocyte ratio (NLR) ( P < 0.001) in comparison to non-refractory anaphylaxis patients. Receiver operating characteristic curve (ROC) analysis demonstrated an optimal PLR cutoff value of 129.5 (area under the ROC curve [AUC] 0.658, sensitivity 73.68%, specificity 61.25%, P = 0.004) and an optimal NLR cutoff value of 4 (AUC 0.736, sensitivity 65.79%, specificity 73.75%, P < 0.001) for refractory anaphylaxis. Multivariate logistic regression analysis revealed a PLR≥129.5 (OR = 4.83, 95% CI: 1.87–12.48) and an NLR≥4 (OR = 4.60, 95% CI: 1.86–11.41) were independently associated with refractory anaphylaxis. Conclusion Elevated PLR and NLR serve as independent indicators significantly associated with refractory anaphylaxis.
Refractory anaphylaxis poses an ongoing, lethal hypersensitivity response that unpredictably involves multiple organs despite appropriate intramuscular (IM) adrenaline injections. Studies on the association of the platelet-to-lymphocyte ratio (PLR) and neutrophil-to-lymphocyte ratio (NLR) concerning anaphylactic severity have yet to be carried out. The study aimed to evaluate the association between blood PLR and NLR levels and refractory anaphylaxis.BackgroundRefractory anaphylaxis poses an ongoing, lethal hypersensitivity response that unpredictably involves multiple organs despite appropriate intramuscular (IM) adrenaline injections. Studies on the association of the platelet-to-lymphocyte ratio (PLR) and neutrophil-to-lymphocyte ratio (NLR) concerning anaphylactic severity have yet to be carried out. The study aimed to evaluate the association between blood PLR and NLR levels and refractory anaphylaxis.We carried out a retrospective cross-sectional study in which medical records of patients with anaphylaxis who sought urgent care at the Emergency Department (ED) of Tertiary Hospital in Hanoi, Vietnam, were evaluated. Based on the United Kingdom Resuscitation Council guidelines in 2021, patients were classified as refractory anaphylaxis if they needed more than two appropriate doses of intramuscular adrenaline for anaphylactic symptoms resolution. Clinical data and laboratory results were obtained in the medical records. Logistic regression analysis determined the association between contributing factors and refractory anaphylaxis.MethodsWe carried out a retrospective cross-sectional study in which medical records of patients with anaphylaxis who sought urgent care at the Emergency Department (ED) of Tertiary Hospital in Hanoi, Vietnam, were evaluated. Based on the United Kingdom Resuscitation Council guidelines in 2021, patients were classified as refractory anaphylaxis if they needed more than two appropriate doses of intramuscular adrenaline for anaphylactic symptoms resolution. Clinical data and laboratory results were obtained in the medical records. Logistic regression analysis determined the association between contributing factors and refractory anaphylaxis.One-hundred eighteen adults (age 51.80 ± 18.25 years) were analyzed, including 38 refractory anaphylaxis patients (32.2%). Refractory anaphylaxis patients exhibited notably elevated platelet-to-lymphocyte ratio (PLR) (P = 0.006) and increased neutrophil-to-lymphocyte ratio (NLR) (P < 0.001) in comparison to non-refractory anaphylaxis patients. Receiver operating characteristic curve (ROC) analysis demonstrated an optimal PLR cutoff value of 129.5 (area under the ROC curve [AUC] 0.658, sensitivity 73.68%, specificity 61.25%, P = 0.004) and an optimal NLR cutoff value of 4 (AUC 0.736, sensitivity 65.79%, specificity 73.75%, P < 0.001) for refractory anaphylaxis. Multivariate logistic regression analysis revealed a PLR≥129.5 (OR = 4.83, 95% CI: 1.87-12.48) and an NLR≥4 (OR = 4.60, 95% CI: 1.86-11.41) were independently associated with refractory anaphylaxis.ResultsOne-hundred eighteen adults (age 51.80 ± 18.25 years) were analyzed, including 38 refractory anaphylaxis patients (32.2%). Refractory anaphylaxis patients exhibited notably elevated platelet-to-lymphocyte ratio (PLR) (P = 0.006) and increased neutrophil-to-lymphocyte ratio (NLR) (P < 0.001) in comparison to non-refractory anaphylaxis patients. Receiver operating characteristic curve (ROC) analysis demonstrated an optimal PLR cutoff value of 129.5 (area under the ROC curve [AUC] 0.658, sensitivity 73.68%, specificity 61.25%, P = 0.004) and an optimal NLR cutoff value of 4 (AUC 0.736, sensitivity 65.79%, specificity 73.75%, P < 0.001) for refractory anaphylaxis. Multivariate logistic regression analysis revealed a PLR≥129.5 (OR = 4.83, 95% CI: 1.87-12.48) and an NLR≥4 (OR = 4.60, 95% CI: 1.86-11.41) were independently associated with refractory anaphylaxis.Elevated PLR and NLR serve as independent indicators significantly associated with refractory anaphylaxis.ConclusionElevated PLR and NLR serve as independent indicators significantly associated with refractory anaphylaxis.
ArticleNumber 100944
Author Nghi, Le Vinh
Hai, Pham Dang
Phuc, Nguyen Hoang
Author_xml – sequence: 1
  givenname: Le Vinh
  surname: Nghi
  fullname: Nghi, Le Vinh
  organization: College of Health Sciences, VinUniversity, Ha Noi, Viet Nam
– sequence: 2
  givenname: Nguyen Hoang
  surname: Phuc
  fullname: Phuc, Nguyen Hoang
  organization: College of Health Sciences, VinUniversity, Ha Noi, Viet Nam
– sequence: 3
  givenname: Pham Dang
  orcidid: 0000-0001-9300-231X
  surname: Hai
  fullname: Hai, Pham Dang
  email: bsphamdanghai@gmail.com
  organization: Medical Intensive Care Unit, 108 Military Central Hospital, Viet Nam
BackLink https://www.ncbi.nlm.nih.gov/pubmed/39220464$$D View this record in MEDLINE/PubMed
BookMark eNqNkluL1TAUhYuMOBf9ByIFX3zpMdemFRFk8DIwoA_6HNJkd06OOU1NUsf-e1M7DnIQjk9JNmutvdlfzouTwQ9QFE8x2mCE65e7za3yOz9tCCIsl1DL2IPiDLe0rRjn-OSv-2lxHuMOoRphTh8Vp7QlBLGanRU3n51K4CBVyVdu3o9br-cEZVDJ-lINphxgSsGPW-v-LYnlGMBYnXyIpe_LAH1Qy2vOdjVuZ6d-2vi4eNgrF-HJ3XlRfH3_7svlx-r604ery7fXleacpwoDJg0ztcHQk5ZTrLHWnRGia3EnEFaKQJ9LFDMjeI9J3bekrhvaiMb0APSiuFpzjVc7OQa7V2GWXln5u-DDjVQhWe1ANhwQ7jnRvaLMENHoZYmdgboRgpomZ_E1axpGNd8q5-4DMZILBLmTKwS5QJArhOx7sfrG4L9PEJPc26jBOTWAn6KkqG0b3jC8tHh-IM1hYcgbkhSLVojMrM6qZ3eqqduDuZ_iD8YsYKtABx9jJvC_g746sGmbFqpDCsq6Y-Y3qxkyzh8WgozawqDzXwigU963PRbw-iBAOztYrdw3mI_bfwFKofEm
CitedBy_id crossref_primary_10_1016_j_ajem_2025_03_017
Cites_doi 10.1016/S0091-6749(99)70107-7
10.1111/ijcp.14655
10.7861/clinmed.2022-0073
10.1002/biof.1956
10.1016/j.jcrc.2021.12.005
10.1016/j.jaci.2004.04.029
10.1016/j.eimc.2020.11.004
10.1111/cea.12418
10.1159/000509116
10.1016/j.waojou.2019.100066
10.1016/j.jaip.2019.11.027
10.1007/s00405-019-05640-0
10.1111/j.1398-9995.2012.02795.x
10.1111/cea.12868
10.1016/j.jaci.2015.06.052
10.1136/bmj.39339.610000.BE
10.1016/j.jaci.2017.06.003
10.1189/jlb.1212623
10.2500/108854199778251834
10.1016/j.micinf.2014.07.004
10.3390/biomedicines10010075
10.1016/j.jaci.2015.04.019
10.1016/j.anai.2018.11.029
10.1016/j.jaci.2012.08.016
10.1155/2015/429534
10.1016/j.waojou.2020.100472
10.1186/s13223-021-00512-x
10.1016/j.alit.2017.05.005
10.1016/0167-5699(87)90010-7
10.1016/S1081-1206(10)61367-1
ContentType Journal Article
Copyright 2024 The Authors
2024 The Authors.
2024. The Authors
Copyright_xml – notice: 2024 The Authors
– notice: 2024 The Authors.
– notice: 2024. The Authors
DBID 6I.
AAFTH
AAYXX
CITATION
NPM
K9.
NAPCQ
7X8
ADTOC
UNPAY
DOA
DOI 10.1016/j.waojou.2024.100944
DatabaseName ScienceDirect Open Access Titles
Elsevier:ScienceDirect:Open Access
CrossRef
PubMed
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Premium
MEDLINE - Academic
Unpaywall for CDI: Periodical Content
Unpaywall
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
PubMed
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Premium
MEDLINE - Academic
DatabaseTitleList PubMed


ProQuest Health & Medical Complete (Alumni)
MEDLINE - Academic

Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: UNPAY
  name: Unpaywall
  url: https://proxy.k.utb.cz/login?url=https://unpaywall.org/
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1939-4551
ExternalDocumentID oai_doaj_org_article_85e01f52cfa34d278c1009bde68773d8
10.1016/j.waojou.2024.100944
39220464
10_1016_j_waojou_2024_100944
S1939455124000759
Genre Journal Article
GeographicLocations United States--US
Vietnam
GeographicLocations_xml – name: Vietnam
– name: United States--US
GroupedDBID ---
.1-
.FO
08G
0R~
123
4.4
53G
5VS
7RV
7X7
8C1
8FI
8FJ
AAEDW
AAKAS
AAKDD
AALRI
AAXUO
AAYWO
ABMAC
ABUWG
ACGFS
ACIHN
ACVFH
ADBBV
ADBIZ
ADCNI
ADRAZ
ADUKV
ADVLN
ADZCM
AEAQA
AEUPX
AEXQZ
AFJKZ
AFKRA
AFPUW
AFRHN
AFTJW
AFTRI
AHBYD
AHMBA
AHSBF
AHYZX
AIGII
AITUG
AIZYK
AJUYK
AKBMS
AKRWK
AKYEP
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AMRAJ
AOIJS
APXCP
AQUVI
ASPBG
AVWKF
BCNDV
BENPR
BFQNJ
BKEYQ
BMC
BPHCQ
BVXVI
C6C
CCPQU
CS3
EBS
EJD
EX3
FDB
FYUFA
GROUPED_DOAJ
GX1
H13
HMCUK
HYE
HZ~
IAO
IHR
IPNFZ
ITC
KD2
KQ8
M0T
M41
M48
M~E
NAPCQ
NTWIH
O9-
OK1
OVD
P2P
PHGZM
PHGZT
PIMPY
PJZUB
PPXIY
PQQKQ
PROAC
PUEGO
RBZ
RIG
RNS
ROL
RPM
RSV
SOJ
SSZ
TEORI
UKHRP
V2I
W3M
WOQ
WOW
Z5R
-A0
0SF
3V.
6I.
AACTN
AAFTH
ACRMQ
ADINQ
ALIPV
C24
IHW
NCXOZ
AAYXX
CITATION
NPM
K9.
7X8
ADTOC
UNPAY
ID FETCH-LOGICAL-c555t-1e1284d6d1ef29531c1ccbd77b91b701aa2ef1cc314d75f126f926683878dfee3
IEDL.DBID UNPAY
ISSN 1939-4551
IngestDate Wed Aug 27 01:04:41 EDT 2025
Wed Aug 20 00:10:57 EDT 2025
Thu Sep 04 23:01:57 EDT 2025
Sat Aug 23 12:53:52 EDT 2025
Mon Jul 21 05:58:43 EDT 2025
Thu Apr 24 22:57:34 EDT 2025
Wed Oct 01 05:05:01 EDT 2025
Sat Aug 31 16:01:07 EDT 2024
Tue Aug 26 16:32:46 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 8
Keywords Platelet-to-lymphocyte ratio
Anaphylaxis
Neutrophil-to-lymphocyte ratio
Adrenaline
Refractory anaphylaxis
Language English
License This is an open access article under the CC BY-NC-ND license.
2024 The Authors.
cc-by-nc-nd
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c555t-1e1284d6d1ef29531c1ccbd77b91b701aa2ef1cc314d75f126f926683878dfee3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0001-9300-231X
OpenAccessLink https://proxy.k.utb.cz/login?url=https://doi.org/10.1016/j.waojou.2024.100944
PMID 39220464
PQID 3179770066
PQPubID 2040184
ParticipantIDs doaj_primary_oai_doaj_org_article_85e01f52cfa34d278c1009bde68773d8
unpaywall_primary_10_1016_j_waojou_2024_100944
proquest_miscellaneous_3099858418
proquest_journals_3179770066
pubmed_primary_39220464
crossref_primary_10_1016_j_waojou_2024_100944
crossref_citationtrail_10_1016_j_waojou_2024_100944
elsevier_sciencedirect_doi_10_1016_j_waojou_2024_100944
elsevier_clinicalkey_doi_10_1016_j_waojou_2024_100944
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate August 2024
2024-08-00
2024-Aug
20240801
2024-08-01
PublicationDateYYYYMMDD 2024-08-01
PublicationDate_xml – month: 08
  year: 2024
  text: August 2024
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: Milwaukee
PublicationTitle The World Allergy Organization journal
PublicationTitleAlternate World Allergy Organ J
PublicationYear 2024
Publisher Elsevier Inc
Elsevier BV
Elsevier
Publisher_xml – name: Elsevier Inc
– name: Elsevier BV
– name: Elsevier
References Tien (bib12) 2017
Jentzer, Szekely, Burstein (bib30) 2022; 68
Francis, Bosio, Stone (bib26) 2017; 47
Drăgoescu, Pădureanu, Stănculescu (bib33) 2021; 10
Braquet, Rola-Pleszcynski (bib18) 1987; 8
Kim, Choi, Park (bib5) 2021; 17
Huang, Huang, Zhan (bib20) 2020; 24
Gill, Jindal, Jagdis, Vadas (bib17) 2015; 135
Mochimaru, Ueda, Suzuki, Asano, Fukunaga (bib27) 2019; 122
Reber, Hernandez, Galli (bib23) 2017; 140
Tian, Zhou, Xia, Shen, Ying (bib16) 2014; 16
Sasmita, Zhu, Gan (bib32) 2021; 75
Whyte, Soar, Dodd, Hughes, Sargant, Turner (bib4) 2022; 22
Kim, Kim, Cho (bib22) 2018; 67
Branicka, Rogala, Glück (bib8) 2020; 181
Pruc, Peacock, Rafique (bib31) 2023; 12
Brown (bib10) 2004; 114
Francuzik, Nassiri, Babina, Worm (bib29) 2015; 136
Worm, Edenharter, Ruëff (bib25) 2012; 67
Wang, Mivefroshan, Yaghoobpoor (bib35) 2022; 2022
Tang, Xu, Cao (bib21) 2015; 2015
Webb, Lieberman (bib28) 2006; 97
Esmaeilzadeh, Nouri, Nabavizadeh, Alyasin, Mortazavi (bib6) 2021; 17
Turner, Campbell, Motosue, Campbell (bib3) 2020; 8
Korenblat, Lundie, Dankner, Day (bib13) 1999; 20
Goodyear, Krleza-Jeric, Lemmens (bib11) 2007; 335
Lorente, Martín, Ortiz-López (bib34) 2022; 40
Göker, Ekincioglu, Alagöz (bib7) 2019; 276
Jönsson, Mancardi, Albanesi, Bruhns (bib24) 2013; 94
Turner, Worm, Ansotegui (bib9) 2019; 12
Vadas, Perelman, Liss (bib19) 2013; 131
Ohta, Yamashita (bib15) 1999; 104
Cardona, Ansotegui, Ebisawa (bib1) 2020; 13
Tejedor Alonso, Moro Moro, Múgica García (bib2) 2015; 45
Pałgan, Tretyn (bib14) 2023; 49
Turner (10.1016/j.waojou.2024.100944_bib9) 2019; 12
Turner (10.1016/j.waojou.2024.100944_bib3) 2020; 8
Tang (10.1016/j.waojou.2024.100944_bib21) 2015; 2015
Brown (10.1016/j.waojou.2024.100944_bib10) 2004; 114
Gill (10.1016/j.waojou.2024.100944_bib17) 2015; 135
Whyte (10.1016/j.waojou.2024.100944_bib4) 2022; 22
Korenblat (10.1016/j.waojou.2024.100944_bib13) 1999; 20
Mochimaru (10.1016/j.waojou.2024.100944_bib27) 2019; 122
Göker (10.1016/j.waojou.2024.100944_bib7) 2019; 276
Cardona (10.1016/j.waojou.2024.100944_bib1) 2020; 13
Francis (10.1016/j.waojou.2024.100944_bib26) 2017; 47
Drăgoescu (10.1016/j.waojou.2024.100944_bib33) 2021; 10
Tejedor Alonso (10.1016/j.waojou.2024.100944_bib2) 2015; 45
Tian (10.1016/j.waojou.2024.100944_bib16) 2014; 16
Kim (10.1016/j.waojou.2024.100944_bib22) 2018; 67
Huang (10.1016/j.waojou.2024.100944_bib20) 2020; 24
Esmaeilzadeh (10.1016/j.waojou.2024.100944_bib6) 2021; 17
Jentzer (10.1016/j.waojou.2024.100944_bib30) 2022; 68
Worm (10.1016/j.waojou.2024.100944_bib25) 2012; 67
Kim (10.1016/j.waojou.2024.100944_bib5) 2021; 17
Jönsson (10.1016/j.waojou.2024.100944_bib24) 2013; 94
Tien (10.1016/j.waojou.2024.100944_bib12) 2017
Francuzik (10.1016/j.waojou.2024.100944_bib29) 2015; 136
Goodyear (10.1016/j.waojou.2024.100944_bib11) 2007; 335
Pałgan (10.1016/j.waojou.2024.100944_bib14) 2023; 49
Reber (10.1016/j.waojou.2024.100944_bib23) 2017; 140
Pruc (10.1016/j.waojou.2024.100944_bib31) 2023; 12
Wang (10.1016/j.waojou.2024.100944_bib35) 2022; 2022
Branicka (10.1016/j.waojou.2024.100944_bib8) 2020; 181
Ohta (10.1016/j.waojou.2024.100944_bib15) 1999; 104
Webb (10.1016/j.waojou.2024.100944_bib28) 2006; 97
Braquet (10.1016/j.waojou.2024.100944_bib18) 1987; 8
Vadas (10.1016/j.waojou.2024.100944_bib19) 2013; 131
Lorente (10.1016/j.waojou.2024.100944_bib34) 2022; 40
Sasmita (10.1016/j.waojou.2024.100944_bib32) 2021; 75
References_xml – volume: 131
  start-page: 144
  year: 2013
  end-page: 149
  ident: bib19
  article-title: Platelet-activating factor, histamine, and tryptase levels in human anaphylaxis
  publication-title: J Allergy Clin Immunol
– volume: 67
  start-page: 96
  year: 2018
  end-page: 102
  ident: bib22
  article-title: Different clinical features of anaphylaxis according to cause and risk factors for severe reactions
  publication-title: Allergol Int
– volume: 16
  start-page: 811
  year: 2014
  end-page: 821
  ident: bib16
  article-title: Balance of apoptotic cell death and survival in allergic diseases
  publication-title: Microb Infect
– volume: 67
  start-page: 691
  year: 2012
  end-page: 698
  ident: bib25
  article-title: Symptom profile and risk factors of anaphylaxis in Central Europe
  publication-title: Allergy
– volume: 8
  start-page: 345
  year: 1987
  end-page: 351
  ident: bib18
  article-title: Platelet-activating factor and cellular immune responses
  publication-title: Immunol Today
– volume: 2015
  year: 2015
  ident: bib21
  article-title: Clinical characteristics of inpatients with anaphylaxis in China
  publication-title: BioMed Res Int
– volume: 22
  start-page: 332
  year: 2022
  end-page: 339
  ident: bib4
  article-title: Emergency treatment of anaphylaxis: concise clinical guidance
  publication-title: Clin Med
– volume: 40
  start-page: 235
  year: 2022
  end-page: 240
  ident: bib34
  article-title: Association between neutrophil-to-lymphocyte ratio in the first seven days of sepsis and mortality
  publication-title: Enferm Infecc Microbiol Clín
– volume: 24
  start-page: 11719
  year: 2020
  end-page: 11728
  ident: bib20
  article-title: The neutrophil to lymphocyte ratio as a novel predictor of asthma and its exacerbation: a systematic review and meta-analysis
  publication-title: Eur Rev Med Pharmacol Sci
– volume: 181
  start-page: 774
  year: 2020
  end-page: 782
  ident: bib8
  article-title: Eosinophil/Neutrophil/Platelet-to-Lymphocyte ratios in various types of immediate hypersensitivity to NSAIDs: a preliminary study
  publication-title: Int Arch Allergy Immunol
– volume: 13
  year: 2020
  ident: bib1
  article-title: World allergy organization anaphylaxis guidance 2020
  publication-title: World Allergy Organization Journal
– volume: 136
  start-page: 1425
  year: 2015
  ident: bib29
  article-title: Impact of sex on anaphylaxis severity—data from the Anaphylaxis Registry
  publication-title: J Allergy Clin Immunol
– volume: 45
  start-page: 1027
  year: 2015
  end-page: 1039
  ident: bib2
  article-title: Epidemiology of anaphylaxis
  publication-title: Clin Exp Allergy
– volume: 12
  start-page: 6903
  year: 2023
  ident: bib31
  article-title: The prognostic role of platelet-to-lymphocyte ratio in acute coronary syndromes: a systematic review and meta-analysis
  publication-title: J Clin Med
– volume: 10
  start-page: 75
  year: 2021
  ident: bib33
  article-title: Neutrophil to lymphocyte ratio (NLR)-A useful tool for the prognosis of sepsis in the ICU
  publication-title: Biomedicines
– volume: 17
  start-page: 16
  year: 2021
  ident: bib6
  article-title: Can eosinophilia and neutrophil–lymphocyte ratio predict hospitalization in asthma exacerbation? Allergy
  publication-title: Asthma & Clinical Immunology
– year: 2017
  ident: bib12
  article-title: Guidelines on Prevention, Diagosis and Management of Anaphylaxis
– volume: 97
  start-page: 39
  year: 2006
  end-page: 43
  ident: bib28
  article-title: Anaphylaxis: a review of 601 cases
  publication-title: Ann Allergy Asthma Immunol
– volume: 135
  start-page: 1424
  year: 2015
  end-page: 1432
  ident: bib17
  article-title: Platelets in the immune response: revisiting platelet-activating factor in anaphylaxis
  publication-title: J Allergy Clin Immunol
– volume: 114
  start-page: 371
  year: 2004
  end-page: 376
  ident: bib10
  article-title: Clinical features and severity grading of anaphylaxis
  publication-title: J Allergy Clin Immunol
– volume: 2022
  year: 2022
  ident: bib35
  article-title: Prognostic value of platelet to lymphocyte ratio in sepsis: a systematic review and meta-analysis
  publication-title: BioMed Res Int
– volume: 94
  start-page: 643
  year: 2013
  end-page: 656
  ident: bib24
  article-title: Neutrophils in local and systemic antibody-dependent inflammatory and anaphylactic reactions
  publication-title: J Leukoc Biol
– volume: 276
  start-page: 3383
  year: 2019
  end-page: 3388
  ident: bib7
  article-title: The association of allergic rhinitis severity with neutrophil–lymphocyte and platelet–lymphocyte ratio in adults
  publication-title: Eur Arch Oto-Rhino-Laryngol
– volume: 75
  year: 2021
  ident: bib32
  article-title: Prognostic value of neutrophil-lymphocyte ratio in cardiogenic shock complicating acute myocardial infarction: a cohort study
  publication-title: Int J Clin Pract
– volume: 335
  start-page: 624
  year: 2007
  end-page: 625
  ident: bib11
  article-title: The declaration of Helsinki
  publication-title: BMJ
– volume: 104
  start-page: 14
  year: 1999
  end-page: 21
  ident: bib15
  article-title: Apoptosis of eosinophils and lymphocytes in allergic inflammation
  publication-title: J Allergy Clin Immunol
– volume: 122
  start-page: 337
  year: 2019
  end-page: 339.e1
  ident: bib27
  article-title: Neutrophil-to-lymphocyte ratio as a novel independent predictor of severe exacerbation in patients with asthma
  publication-title: Ann Allergy Asthma Immunol
– volume: 49
  start-page: 976
  year: 2023
  end-page: 983
  ident: bib14
  article-title: Platelet-activating factor as an endogenous cofactor of food anaphylaxis
  publication-title: Biofactors
– volume: 12
  year: 2019
  ident: bib9
  article-title: Time to revisit the definition and clinical criteria for anaphylaxis?
  publication-title: World Allergy Organization Journal
– volume: 8
  start-page: 1169
  year: 2020
  end-page: 1176
  ident: bib3
  article-title: Global trends in anaphylaxis epidemiology and clinical implications
  publication-title: J Allergy Clin Immunol Pract
– volume: 140
  start-page: 335
  year: 2017
  end-page: 348
  ident: bib23
  article-title: The pathophysiology of anaphylaxis
  publication-title: J Allergy Clin Immunol
– volume: 17
  start-page: 158
  year: 2021
  end-page: 166
  ident: bib5
  article-title: The association between neutrophil-to-lymphocyte ratio and anaphylaxis refractory to epinephrine treatment
  publication-title: Signa Vitae
– volume: 47
  start-page: 361
  year: 2017
  end-page: 370
  ident: bib26
  article-title: Neutrophil activation during acute human anaphylaxis: analysis of MPO and sCD62L
  publication-title: Clin Exp Allergy
– volume: 68
  start-page: 50
  year: 2022
  end-page: 58
  ident: bib30
  article-title: Peripheral blood neutrophil-to-lymphocyte ratio is associated with mortality across the spectrum of cardiogenic shock severity
  publication-title: J Crit Care
– volume: 20
  start-page: 383
  year: 1999
  end-page: 386
  ident: bib13
  article-title: A retrospective study of epinephrine administration for anaphylaxis: how many doses are needed?
  publication-title: Allergy Asthma Proc
– volume: 104
  start-page: 14
  issue: 1
  year: 1999
  ident: 10.1016/j.waojou.2024.100944_bib15
  article-title: Apoptosis of eosinophils and lymphocytes in allergic inflammation
  publication-title: J Allergy Clin Immunol
  doi: 10.1016/S0091-6749(99)70107-7
– volume: 75
  issue: 10
  year: 2021
  ident: 10.1016/j.waojou.2024.100944_bib32
  article-title: Prognostic value of neutrophil-lymphocyte ratio in cardiogenic shock complicating acute myocardial infarction: a cohort study
  publication-title: Int J Clin Pract
  doi: 10.1111/ijcp.14655
– volume: 12
  start-page: 6903
  issue: 21
  year: 2023
  ident: 10.1016/j.waojou.2024.100944_bib31
  article-title: The prognostic role of platelet-to-lymphocyte ratio in acute coronary syndromes: a systematic review and meta-analysis
  publication-title: J Clin Med
– volume: 2022
  year: 2022
  ident: 10.1016/j.waojou.2024.100944_bib35
  article-title: Prognostic value of platelet to lymphocyte ratio in sepsis: a systematic review and meta-analysis
  publication-title: BioMed Res Int
– volume: 22
  start-page: 332
  issue: 4
  year: 2022
  ident: 10.1016/j.waojou.2024.100944_bib4
  article-title: Emergency treatment of anaphylaxis: concise clinical guidance
  publication-title: Clin Med
  doi: 10.7861/clinmed.2022-0073
– volume: 49
  start-page: 976
  issue: 5
  year: 2023
  ident: 10.1016/j.waojou.2024.100944_bib14
  article-title: Platelet-activating factor as an endogenous cofactor of food anaphylaxis
  publication-title: Biofactors
  doi: 10.1002/biof.1956
– volume: 68
  start-page: 50
  year: 2022
  ident: 10.1016/j.waojou.2024.100944_bib30
  article-title: Peripheral blood neutrophil-to-lymphocyte ratio is associated with mortality across the spectrum of cardiogenic shock severity
  publication-title: J Crit Care
  doi: 10.1016/j.jcrc.2021.12.005
– volume: 114
  start-page: 371
  issue: 2
  year: 2004
  ident: 10.1016/j.waojou.2024.100944_bib10
  article-title: Clinical features and severity grading of anaphylaxis
  publication-title: J Allergy Clin Immunol
  doi: 10.1016/j.jaci.2004.04.029
– volume: 40
  start-page: 235
  issue: 5
  year: 2022
  ident: 10.1016/j.waojou.2024.100944_bib34
  article-title: Association between neutrophil-to-lymphocyte ratio in the first seven days of sepsis and mortality
  publication-title: Enferm Infecc Microbiol Clín
  doi: 10.1016/j.eimc.2020.11.004
– volume: 45
  start-page: 1027
  issue: 6
  year: 2015
  ident: 10.1016/j.waojou.2024.100944_bib2
  article-title: Epidemiology of anaphylaxis
  publication-title: Clin Exp Allergy
  doi: 10.1111/cea.12418
– volume: 181
  start-page: 774
  issue: 10
  year: 2020
  ident: 10.1016/j.waojou.2024.100944_bib8
  article-title: Eosinophil/Neutrophil/Platelet-to-Lymphocyte ratios in various types of immediate hypersensitivity to NSAIDs: a preliminary study
  publication-title: Int Arch Allergy Immunol
  doi: 10.1159/000509116
– volume: 12
  issue: 10
  year: 2019
  ident: 10.1016/j.waojou.2024.100944_bib9
  article-title: Time to revisit the definition and clinical criteria for anaphylaxis?
  publication-title: World Allergy Organization Journal
  doi: 10.1016/j.waojou.2019.100066
– volume: 8
  start-page: 1169
  issue: 4
  year: 2020
  ident: 10.1016/j.waojou.2024.100944_bib3
  article-title: Global trends in anaphylaxis epidemiology and clinical implications
  publication-title: J Allergy Clin Immunol Pract
  doi: 10.1016/j.jaip.2019.11.027
– volume: 276
  start-page: 3383
  issue: 12
  year: 2019
  ident: 10.1016/j.waojou.2024.100944_bib7
  article-title: The association of allergic rhinitis severity with neutrophil–lymphocyte and platelet–lymphocyte ratio in adults
  publication-title: Eur Arch Oto-Rhino-Laryngol
  doi: 10.1007/s00405-019-05640-0
– volume: 67
  start-page: 691
  issue: 5
  year: 2012
  ident: 10.1016/j.waojou.2024.100944_bib25
  article-title: Symptom profile and risk factors of anaphylaxis in Central Europe
  publication-title: Allergy
  doi: 10.1111/j.1398-9995.2012.02795.x
– volume: 47
  start-page: 361
  issue: 3
  year: 2017
  ident: 10.1016/j.waojou.2024.100944_bib26
  article-title: Neutrophil activation during acute human anaphylaxis: analysis of MPO and sCD62L
  publication-title: Clin Exp Allergy
  doi: 10.1111/cea.12868
– volume: 136
  start-page: 1425
  issue: 5
  year: 2015
  ident: 10.1016/j.waojou.2024.100944_bib29
  article-title: Impact of sex on anaphylaxis severity—data from the Anaphylaxis Registry
  publication-title: J Allergy Clin Immunol
  doi: 10.1016/j.jaci.2015.06.052
– volume: 335
  start-page: 624
  issue: 7621
  year: 2007
  ident: 10.1016/j.waojou.2024.100944_bib11
  article-title: The declaration of Helsinki
  publication-title: BMJ
  doi: 10.1136/bmj.39339.610000.BE
– volume: 140
  start-page: 335
  issue: 2
  year: 2017
  ident: 10.1016/j.waojou.2024.100944_bib23
  article-title: The pathophysiology of anaphylaxis
  publication-title: J Allergy Clin Immunol
  doi: 10.1016/j.jaci.2017.06.003
– volume: 94
  start-page: 643
  issue: 4
  year: 2013
  ident: 10.1016/j.waojou.2024.100944_bib24
  article-title: Neutrophils in local and systemic antibody-dependent inflammatory and anaphylactic reactions
  publication-title: J Leukoc Biol
  doi: 10.1189/jlb.1212623
– volume: 20
  start-page: 383
  issue: 6
  year: 1999
  ident: 10.1016/j.waojou.2024.100944_bib13
  article-title: A retrospective study of epinephrine administration for anaphylaxis: how many doses are needed?
  publication-title: Allergy Asthma Proc
  doi: 10.2500/108854199778251834
– volume: 16
  start-page: 811
  issue: 10
  year: 2014
  ident: 10.1016/j.waojou.2024.100944_bib16
  article-title: Balance of apoptotic cell death and survival in allergic diseases
  publication-title: Microb Infect
  doi: 10.1016/j.micinf.2014.07.004
– volume: 24
  start-page: 11719
  issue: 22
  year: 2020
  ident: 10.1016/j.waojou.2024.100944_bib20
  article-title: The neutrophil to lymphocyte ratio as a novel predictor of asthma and its exacerbation: a systematic review and meta-analysis
  publication-title: Eur Rev Med Pharmacol Sci
– volume: 10
  start-page: 75
  issue: 1
  year: 2021
  ident: 10.1016/j.waojou.2024.100944_bib33
  article-title: Neutrophil to lymphocyte ratio (NLR)-A useful tool for the prognosis of sepsis in the ICU
  publication-title: Biomedicines
  doi: 10.3390/biomedicines10010075
– volume: 135
  start-page: 1424
  issue: 6
  year: 2015
  ident: 10.1016/j.waojou.2024.100944_bib17
  article-title: Platelets in the immune response: revisiting platelet-activating factor in anaphylaxis
  publication-title: J Allergy Clin Immunol
  doi: 10.1016/j.jaci.2015.04.019
– year: 2017
  ident: 10.1016/j.waojou.2024.100944_bib12
– volume: 122
  start-page: 337
  issue: 3
  year: 2019
  ident: 10.1016/j.waojou.2024.100944_bib27
  article-title: Neutrophil-to-lymphocyte ratio as a novel independent predictor of severe exacerbation in patients with asthma
  publication-title: Ann Allergy Asthma Immunol
  doi: 10.1016/j.anai.2018.11.029
– volume: 131
  start-page: 144
  issue: 1
  year: 2013
  ident: 10.1016/j.waojou.2024.100944_bib19
  article-title: Platelet-activating factor, histamine, and tryptase levels in human anaphylaxis
  publication-title: J Allergy Clin Immunol
  doi: 10.1016/j.jaci.2012.08.016
– volume: 2015
  year: 2015
  ident: 10.1016/j.waojou.2024.100944_bib21
  article-title: Clinical characteristics of inpatients with anaphylaxis in China
  publication-title: BioMed Res Int
  doi: 10.1155/2015/429534
– volume: 13
  issue: 10
  year: 2020
  ident: 10.1016/j.waojou.2024.100944_bib1
  article-title: World allergy organization anaphylaxis guidance 2020
  publication-title: World Allergy Organization Journal
  doi: 10.1016/j.waojou.2020.100472
– volume: 17
  start-page: 158
  issue: 3
  year: 2021
  ident: 10.1016/j.waojou.2024.100944_bib5
  article-title: The association between neutrophil-to-lymphocyte ratio and anaphylaxis refractory to epinephrine treatment
  publication-title: Signa Vitae
– volume: 17
  start-page: 16
  issue: 1
  year: 2021
  ident: 10.1016/j.waojou.2024.100944_bib6
  article-title: Can eosinophilia and neutrophil–lymphocyte ratio predict hospitalization in asthma exacerbation? Allergy
  publication-title: Asthma & Clinical Immunology
  doi: 10.1186/s13223-021-00512-x
– volume: 67
  start-page: 96
  issue: 1
  year: 2018
  ident: 10.1016/j.waojou.2024.100944_bib22
  article-title: Different clinical features of anaphylaxis according to cause and risk factors for severe reactions
  publication-title: Allergol Int
  doi: 10.1016/j.alit.2017.05.005
– volume: 8
  start-page: 345
  issue: 11
  year: 1987
  ident: 10.1016/j.waojou.2024.100944_bib18
  article-title: Platelet-activating factor and cellular immune responses
  publication-title: Immunol Today
  doi: 10.1016/0167-5699(87)90010-7
– volume: 97
  start-page: 39
  issue: 1
  year: 2006
  ident: 10.1016/j.waojou.2024.100944_bib28
  article-title: Anaphylaxis: a review of 601 cases
  publication-title: Ann Allergy Asthma Immunol
  doi: 10.1016/S1081-1206(10)61367-1
SSID ssj0060153
Score 2.3306003
Snippet Refractory anaphylaxis poses an ongoing, lethal hypersensitivity response that unpredictably involves multiple organs despite appropriate intramuscular (IM)...
Background Refractory anaphylaxis poses an ongoing, lethal hypersensitivity response that unpredictably involves multiple organs despite appropriate...
Background: Refractory anaphylaxis poses an ongoing, lethal hypersensitivity response that unpredictably involves multiple organs despite appropriate...
SourceID doaj
unpaywall
proquest
pubmed
crossref
elsevier
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 100944
SubjectTerms Adrenaline
Airway management
Allergens
Allergies
Anaphylaxis
Blood platelets
Blood pressure
Blood tests
Cross-sectional studies
Histamine
Hypotension
Laboratories
Leukocytes
Lymphocytes
Mortality
Neutrophil-to-lymphocyte ratio
Neutrophils
Ostomy
Patients
Platelet-to-lymphocyte ratio
Refractory anaphylaxis
Regression analysis
Urticaria
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1La9wwEBYlhz4OJX07SYsLvaqNXrZ8TENCKKT00EBuQpZG7RZjL7te0v33HVm2SWhhc-jV1siyvpHmGzSaIeRDBZVETyNQqCynuBKBavTBaBW8tOC9rIe0i5dfi4sr-eVaXd8q9RVjwlJ64DRxn7SCYxYUd8EK6XmpHUNaUHsodFkKP1zzRTM2OVNpD0YvQ4npotwQzXVjOwQH_UEuY2BAJeUdQzTk679jj_7mm0_Io027tNsb2zS3bND5Pnk6ksf8JA36GXkA7XPy8HI8Hn9BfnxrkDoiErTvaLNFoDq37SEfUM5t6_MWNv2qW_5cNP9uss6Xq9hdrMGTdyHHYa-GijxbFI-prRv7e7F-Sa7Oz76fXtCxkgJ1SqmeMohmyBeeQeAVLjvHnKt9WdYVq8tjZi2HgI8Ek75UgfEiVGi5tdCl9gFAvCJ7bdfCG5KzQnEVOA_CF9I6jaAW6AUBYoD9WZERMU2rcWOa8VjtojFTPNkvk8AwEQyTwMgInaWWKc3GjvafI2Jz25gke3iAqmNG1TG7VCcjasLbTPdQcefEjhY7Pl7OciNPSfzjHpJHk1qZca9YG2RwSMIj98vI-_k1rvJ4dGNb6DbYBom8Rq7IcNCvkzrO_44Ml8cD6ox8nPXzXpN48D8m8ZA8jl2mmMgjstevNvAWeVpfvxuW5B92qjta
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: Scholars Portal Journals: Open Access
  dbid: M48
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1Lb9QwEB6VIvE4IN4NFBQkxM1V7diJc0AIEFWFtIgDK_VmObHdLoqSNJtVm3_fcV5QUdS9Oh7b8cx4vtHYMwDvU5ty9DQcsalmBDXREok-GEmd4doaw7M-7eLiR3y85N9PxMkOTIH2cQPXN7p2vp7UsikOLs-7T6jwH__c1brQFVKit8e4D_unnH-oz4kvLeVDsGOdjTtwF80V86K_4HOoAR2SPlUlApmUcMQP0_u6_wx8zX71af6vmbF_YepDuL8pa91d6KL4y3QdPYZHI-YMPw9C8gR2bPkU7i3GqPozOP1ZIOJEBpK2IkWH_K3yrrVhLxyhLk1Y2k3bVPXZqri5yzqsGz-cL90TVi7EZTd9IZ8OyX1G7EJfrtbPYXn07dfXYzIWYCC5EKIl1HrrZWJDrWMpamtO8zwzSZKlNEsOqdbMOmyKKDeJcJTFLkWDLyOZSOOsjV7AblmVdg9CGgsmHGMuMjHXuURZiNF5sohAcDwdBRBN26ryMTu5L5JRqOka2m81MEN5ZqiBGQGQmaoesnPc0v-L59jc1-fW7huq5lSNqqqksIfUCZY7HXHDEpl74szYWCZJZGQAYuK3mp6v4oGLA61umTyZ6UZ4M8CWLSj3J7FSk4YoBH6I3T1kDODd_BkPBx_x0aWtNtgH8b9EiElx0S8HcZz_HYEx83HtAA5m-dxqE19tMd1reOAphpuS-7DbNhv7BtFbm73tte8KyuhDeQ
  priority: 102
  providerName: Scholars Portal
Title Platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio as predictors of refractory anaphylaxis
URI https://www.clinicalkey.com/#!/content/1-s2.0-S1939455124000759
https://dx.doi.org/10.1016/j.waojou.2024.100944
https://www.ncbi.nlm.nih.gov/pubmed/39220464
https://www.proquest.com/docview/3179770066
https://www.proquest.com/docview/3099858418
https://doi.org/10.1016/j.waojou.2024.100944
https://doaj.org/article/85e01f52cfa34d278c1009bde68773d8
UnpaywallVersion publishedVersion
Volume 17
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVADU
  databaseName: BioMed Central Open Access Free
  customDbUrl:
  eissn: 1939-4551
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0060153
  issn: 1939-4551
  databaseCode: RBZ
  dateStart: 20080101
  isFulltext: true
  titleUrlDefault: https://www.biomedcentral.com/search/
  providerName: BioMedCentral
– providerCode: PRVAFT
  databaseName: Open Access Digital Library
  customDbUrl:
  eissn: 1939-4551
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0060153
  issn: 1939-4551
  databaseCode: KQ8
  dateStart: 20080101
  isFulltext: true
  titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html
  providerName: Colorado Alliance of Research Libraries
– providerCode: PRVAON
  databaseName: DOAJ Directory of Open Access Journals
  customDbUrl:
  eissn: 1939-4551
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0060153
  issn: 1939-4551
  databaseCode: DOA
  dateStart: 20080101
  isFulltext: true
  titleUrlDefault: https://www.doaj.org/
  providerName: Directory of Open Access Journals
– providerCode: PRVFQY
  databaseName: GFMER Free Medical Journals
  customDbUrl:
  eissn: 1939-4551
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0060153
  issn: 1939-4551
  databaseCode: GX1
  dateStart: 0
  isFulltext: true
  titleUrlDefault: http://www.gfmer.ch/Medical_journals/Free_medical.php
  providerName: Geneva Foundation for Medical Education and Research
– providerCode: PRVHPJ
  databaseName: ROAD: Directory of Open Access Scholarly Resources (selected full-text only)
  customDbUrl:
  eissn: 1939-4551
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0060153
  issn: 1939-4551
  databaseCode: M~E
  dateStart: 20080101
  isFulltext: true
  titleUrlDefault: https://road.issn.org
  providerName: ISSN International Centre
– providerCode: PRVLSH
  databaseName: Elsevier Journals
  customDbUrl:
  mediaType: online
  eissn: 1939-4551
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0060153
  issn: 1939-4551
  databaseCode: AKRWK
  dateStart: 20080101
  isFulltext: true
  providerName: Library Specific Holdings
– providerCode: PRVAQN
  databaseName: PubMed Central
  customDbUrl:
  eissn: 1939-4551
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0060153
  issn: 1939-4551
  databaseCode: RPM
  dateStart: 20080101
  isFulltext: true
  titleUrlDefault: https://www.ncbi.nlm.nih.gov/pmc/
  providerName: National Library of Medicine
– providerCode: PRVFZP
  databaseName: Scholars Portal Journals: Open Access
  customDbUrl:
  eissn: 1939-4551
  dateEnd: 20250831
  omitProxy: true
  ssIdentifier: ssj0060153
  issn: 1939-4551
  databaseCode: M48
  dateStart: 20080101
  isFulltext: true
  titleUrlDefault: http://journals.scholarsportal.info
  providerName: Scholars Portal
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9QwEB6VrQTiwPsRVKogccSrxrET59giqgppqwqxUuFiOX7QhShZ7SYqy69nnJdYHupyycGZcezx2PNNxh4DvM5sxtDTcMRmihKciZYI9MFI5gxT1hiWt2kXZ-fJ2Zy9v-SXe_BmOAuzFb9v92FdqwrFip4cZT6knzF2C_YTH06awP78_OL4Uxc4zghD6z-cjvsH65b1aZP0bxmhP0HmXbjTlEu1uVZF8YvhOb0Ps6HJ3X6Tb9Omzqf6x2_ZHHft0wO41yPQ8LhTmYewZ8tHcHvWx9gfw5eLAvEnDiepK1JscLQrvalt2KpKqEoTlrapV9XyalH8nWQdLle-On-RT1i5EMWwaq_12SC7z49dqO-L9ROYn777-PaM9NcxEM05r0lkvS0ziYmsoxnOXR1pnZs0zbMoT48ipah1WBRHzKTcRTRxGZp_EYtUGGdt_BQmZVXa5xBGCafcUepikzClBWpGgq6URTyC9ak4gHgYJqn7XOX-yoxCDpvSvspOhtLLUHYyDICMXMsuV8cN9CdeA0Zan2m7LcDBkv3ElYLbo8hxqp2KmaGp0J45NzYRaRobEQAf9EcOh1lx-cWKFjd8PB35erDTgZgdOA8GNZX9grOWCAMRyXsAGcCr8TUuFT7-o0pbNUiD3oBAwBlho5916j32HWEy9VHuAKajvu8kxBf_y3AAk3rV2JeI5er8sP0Hgs8ZE_j8cPL5sJ_UPwFpr0pF
linkProvider Unpaywall
linkToUnpaywall http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9QwEB6VrQTiwPuxqKAgccSr2rET51gQVYW0VQ-sVE6W4wdsiZLVbqKy_HrGeYnloS5XZ8axxzOebzT2GOBN5jKOkYYnLtOMoCU6IjEGI5m3XDtred6WXZyfJ2cL_vFSXB7A2-EuzE7-vj2Hda0rFCtGcoyHlH7G-S04TEI6aQKHi_OLk89d4jgjHL3_cDvuH6w73qct0r_jhP4EmXfhTlOu9PZaF8Uvjuf0PsyHIXfnTb7NmjqfmR-_VXPcd04P4F6PQKOTTmUewoErH8HteZ9jfwxfLgrEn7icpK5IscXVrsy2dlGrKpEubVS6pl5Xq6_L4u8km2i1Dt2Fh3yiykcohnX7rM8W2UN97EJ_X26ewOL0w6f3Z6R_joEYIURNqAu-zCaWOs8ytF1DjcltmuYZzdNjqjVzHptiym0qPGWJz9D9y1im0nrn4qcwKavSPYeIJoIJz5iPbcK1kagZCYZSDvEI9qfjKcTDMinT1yoPT2YUajiUdqU6GaogQ9XJcApk5Fp1tTpuoH8XNGCkDZW22wZcLNUbrpLCHVMvmPE65pal0gTm3LpEpmls5RTEoD9quMyK2y92tLzh5-nI14OdDsTswXk0qKnqN5yNQhiISD4AyCm8Hj_jVhHyP7p0VYM0GA1IBJwUB_2sU-9x7giTWchyT2E26vteQnzxvwxHMKnXjXuJWK7OX_Um_BNTuEdn
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Platelet-to-lymphocyte+ratio+and+neutrophil-to-lymphocyte+ratio+as+predictors+of+refractory+anaphylaxis&rft.jtitle=The+World+Allergy+Organization+journal&rft.au=Nghi%2C+Le+Vinh&rft.au=Phuc%2C+Nguyen+Hoang&rft.au=Hai%2C+Pham+Dang&rft.date=2024-08-01&rft.issn=1939-4551&rft.eissn=1939-4551&rft.volume=17&rft.issue=8&rft.spage=100944&rft_id=info:doi/10.1016%2Fj.waojou.2024.100944&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1939-4551&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1939-4551&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1939-4551&client=summon